Cite
HARVARD Citation
Rautenberg, C. et al. (n.d.). Sorafenib and azacitidine as salvage therapy for relapse of FLT3‐ITD mutated AML after allo‐SCT. European journal of haematology. pp. 348-354. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rautenberg, C. et al. (n.d.). Sorafenib and azacitidine as salvage therapy for relapse of FLT3‐ITD mutated AML after allo‐SCT. European journal of haematology. pp. 348-354. [Online].